Calquence 100mg (acalabrutinib)

Home - - Calquence 100mg (acalabrutinib)

Calquence 100mg (acalabrutinib)

International Name : Calquence 100mg (acalabrutinib)

Contains : Acalabrutinib

Manufacturer : AstraZeneca Pharmaceuticals LP

Form : Capsules

Packing : Bottle containing 60 capsules

Strength : 100mg

Click Here To Get A Quote

Calquence 100mg (acalabrutinib)

Acalabrutinib is utilized to treat individuals with mantle cell lymphoma (MCL; a quickly developing cancer that begins in the cells of the immune system) who have just been treated with no less than one other chemotherapy drug. Acalabrutinib is in a class of drugs called kinase inhibitors. It works by obstructing the activity of the abnormal protein that signals cancer cells to multiply. This helps to stop the spread of cancer cells.

CALQUENCE is a physician recommended drug used to treat adults with mantle cell lymphoma (MCL) who have gotten something like one earlier treatment for their malignant growth.

It isn’t known whether CALQUENCE is safe and successful in children.


Store at 20°C-25°C (68°F-77°F); excursions allowed to 15°C-30°C (59°F-86°F) [see USP Controlled Room Temperature].

Keep CALQUENCE and all meds out of the reach of kids.

In case of emergency/overdose:

In case of overdose, call the toxic(poison )substance control helpline at 1-800-222-1222. Data is also accessible online at In the event that the unfortunate casualty has fell, had a seizure, experiences difficulty breathing, or can’t be stirred, quickly call emergency services at 911.

Side Effects:

  • headache
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal pain
  • rash
  • small red or purple spots on skin
  • muscle pain
  • extreme tiredness,
  • feeling dizzy,
  • weak, or confused;
  • changes in speech;
  • headache that lasts a long time

This is not a exhaustive list of side effects and others may occur.Please contact your doctor immediately if any of these symptoms are found.


Enquiry about Calquence 100mg (acalabrutinib)

    × How can I help you?